BIOFARM BUCURESTI
Sentinellis health
8.3/10
Financially healthy
Market capitalisation
RON 1.3B
Revenue (TTM)
RON 316.7M
I · AI Analysis
The brief
Biofarm manufactures a broad portfolio of pharmaceutical products including cardiovascular, digestive and metabolic, genito-urinary, ophthalmological, endocrine, nervous system, osteo-muscular, respiratory, multivitamin, antiallergen, and dermatological medications [Company Overview]. The company operates in Romania's generic and specialty drug market, with nearly a century of operating history since its 1921 founding [Company Overview].
Biofarm is a Romanian pharmaceutical manufacturer founded in 1921, producing generic and specialty drugs across cardiovascular, metabolic, respiratory, and other therapeutic categories [Company Overview]. As of June 24, 2026, Biofarm operates as a subsidiary of Poland's Polpharma SA following a voluntary public takeover offer [Company Overview][Dentons]. The company employs 374 people and is based in Bucharest [Company Overview].
Biofarm is financially healthy with exceptional margins, negative net debt, and strong profitability despite recent revenue headwinds.
II · Recent news
What moved
2 stories · ranked by relevance
- macro2026-07-23
Dentons advises Biofarm and its majority shareholders on landmark acquisition by Polpharma through voluntary public takeover offer - Dentons
Dentons
- macro2026-07-22
Romania’s Biofarm becomes part of Polish Polpharma - Romania Insider
Romania Insider
Premium · Free with any account
Risk Analysis
Opportunities
Full Financials
Executive Team
Unlock the full BIOFARM BUCURESTI analysis
Create a free account to access the complete AI-generated report with inline citations.
- Risks, opportunities, and red flags with sources
- 100+ financial metrics with charts and benchmarks
- Full news summaries with source links
- Executive team and compensation details
- PDF export for offline use
III · Related
You might also read
Same sector · Healthcare or comparable health
Want this for your watchlist?